Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Parkinson's disease motor dysfunctions are associated with improperly organised neural oscillatory activity. The presence of such disruption at the early stages of the disease in which altered sleep is one of the main features could be a relevant predictive feature. Based on this, we aimed to investigate the neocortical synchronisation dynamics during slow-wave sleep (SWS) in the rotenone model of Parkinson's disease. After rotenone administration within the substantia nigra pars compacta, one group of male Wistar rats underwent sleep-wake recording. Considering the association between SWS oscillatory activity and memory consolidation, another group of rats underwent a memory test. The fine temporal structure of synchronisation dynamics was evaluated by a recently developed technique called first return map. We observed that rotenone administration decreased the time spent in SWS and altered the power spectrum within different frequency bands, whilst it increased the transition rate from a synchronised to desynchronised state. This neurotoxin also increased the probability of longer and decreased the probability of shorter desynchronisation events. At the same time, we observed impairment in object recognition memory. These findings depict an electrophysiological fingerprint represented by a disruption in the typical oscillatory activity within the neocortex at the early stages of Parkinson's disease, concomitant with a decrease in the time spent in SWS and impairment in recognition memory. © 2020 European Sleep Research Society.


Gustavo Zampier Dos Santos Lima, Adriano D S Targa, Samantha de Freitas Cavalcante, Lais S Rodrigues, John Fontenele-Araújo, Pablo Torterolo, Monica L Andersen, Marcelo M S Lima. Disruption of neocortical synchronisation during slow-wave sleep in the rotenone model of Parkinson's disease. Journal of sleep research. 2021 Jun;30(3):e13170

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 32865294

View Full Text